The FDA has sent warning letters, Novo Nordisk and Eli Lilly have sued various telehealth companies and judges have issued injunctions aimed at stopping the production of copycat drugs
10.1185/03007995.2016.1168291 [DOI] [PubMed] [Google Scholar] 4.Gonzalez-Muniesa P, Martinez-Gonzalez MA, Hu FB, Despres JP, Matsuzawa Y, Loos RJF, et al
A recent Alzheimers and Dementia study uses real-world data in the United States to evaluate the protective role of semaglutide against Alzherimers disease (AD)
Su, C.-C
Rates of nausea were notably higher than with tirzepatide alone, which is consistent with the additive effect on gastric motility
Shortly after Ozempic gained approval, Novo Nordisk conducted a 68-week randomized, double-blind, placebo-controlled trial in participants without type 2 diabetes